-
福沙吡坦杂质G
- names:
Fosaprepitant Impurity G
- CAS号:
170729-80-3
MDL Number: - MF(分子式): C23H21F7N4O3 MW(分子量): 534.43
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YPZZ61717-10mg | 10mg | 0.98 | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 |
| 中文别名 | 福沙吡坦杂质;福沙匹坦杂质 |
| 英文别名 | 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one |
| CAS号 | 170729-80-3 |
| Inchi | InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1CopyCopied |
| InchiKey | ATALOFNDEOCMKK-OITMNORJSA-NCopyCopied |
| 分子式 Formula | C23H21F7N4O3 |
| 分子量 Molecular Weight | 534.43 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions |
杂质产品注意事项:1、普通杂质产品需要提供核磁[氢谱、碳谱(如氢谱不能证明该化合物的情况下)]、LC-MS图谱、色谱图、手性化合物需要核磁二维图谱表征。
| 产品说明 | 福沙吡坦杂质G是合成福沙吡坦过程中产生多余的化学物质它会与药物活性成分(API)一起保留,这些有害化学物质的存在,可能影响药品的功效和安全性。 |
| Introduction | Fosaprepitant Impurity G is a impurity of Fosapr. It will remain with the active pharmaceutical ingredients (API). The presence of these harmful chemicals may affect the efficacy and safety of the drug. |
| Application1 | |
| Application2 | |
| Application3 |
| 警示图 | |
| 危险性 | |
| 危险性警示 | 暂无数据 |
| 安全声明 | CAUTION: May irritate eyes, skin |
| 安全防护 | |
| 备注 |
| Suzuki S; Karayama M; Inui N; Masuda M; Yamada T; Watanabe H; Hayakawa H; Suda T; Kuroishi S; Fujisawa T; Enomoto N; Nakamura Y; Yokomura K; Toyoshima M; Imokawa S; Asada K.Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.,Medical oncology (Northwood, London, England)[PubMed: 27235141] |
| Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism,Cancer Chemotherapy and Pharmacology[DOI: 10.1007s00280-005-1005-4] |
| Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward,Psychopharmacology[DOI: 10.1007s00213-016-4504-6] |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


